Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Supermarket Income REIT secures new £90m Barclays facility

(Sharecast News) - Supermarket Income REIT announced on Thursday that it has secured a new £90m unsecured debt facility with Barclays, which would be used to refinance its existing secured borrowings with Wells Fargo and Bayerische Landesbank. The FTSE 250 company said the facility replaced £85.4m of debt due to mature within the next 12 months, and would result in the cancellation of those facilities in full.

It said the new interest-only facility had an initial term of three years, with two one-year extension options at Barclays' discretion.

It was priced at a margin of 1.55% over SONIA.

The company said it would use the value of its existing interest rate hedges to cap the facility's interest rate at 5% over the initial term, without incurring additional cost.

Following the refinancing and the completion of a recently-announced joint venture, Supermarket Income REIT said it expected to report a pro-forma loan-to-value ratio of about 31%.

"This new facility continues our relationship with Barclays, a key funding partner to the company," said chief executive officer Robert Abraham.

"Our strong relationships with existing lenders and the quality of Supermarket Income REIT's portfolio continue to allow the company to access debt financing at attractive margins."

At 1119 BST, shares in Supermarket Income REIT were up 0.39% at 77.9p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.